Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)

NCT07564947 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

40

Enrollment

OTHER

Sponsor class

Conditions

MAFLD
Fatty Liver
Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD
Fatty Liver, Nonalcoholic
Fatty Liver Disease
Oxidative Stress
Inflammation

Interventions

DIETARY_SUPPLEMENT: Starch Placebo
DIETARY_SUPPLEMENT: Ganoderma lucidum

Sponsor

University of Agriculture, Peshawar